An emerging role for LOX-1 involves oxLDL interactions promoting cancer development: LOX-1-dependent activation of canonical MAPK and NF-κB pathways could cause changes in metabolism, cell proliferation, migration and invasion [57,58]. The gene discussed is NFKB1; the disease is cancer.